Navigation Links
Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
Date:8/12/2008

SAN DIEGO, Aug. 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced the publication of three clinical trials on the use of OraVerse (phentolamine mesylate) injection as a local dental anesthetic reversal agent in the August 2008 issue of the Journal of the American Dental Association (JADA). The first publication, entitled "Reversal of soft tissue local anesthesia with phentolamine mesylate in adolescents and adults" includes an overview of two pivotal trials while the second publication "Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients" reviews the pediatric Phase 2 data. Together these key Novalar-sponsored clinical trials were the foundation for the FDA approval of OraVerse in May 2008.

"JADA's publication of these trials highlights the importance and value of these data to the dental community," commented Athena Papas, DMD, Ph.D., Professor at Tufts University School of Dental Medicine, Novalar Scientific Advisor and co-author on both publications. "Many dental patients, including children, could benefit from this clinical research which found that OraVerse helped patients regain sensation to their lips and tongue in approximately half the time following routine dental procedures."

The first publication details the efficacy and safety of OraVerse in reducing the duration of soft tissue anesthesia in patients receiving standard local anesthetic injections in two Phase 3 clinical trials. Median recovery times in the lower lip and tongue were 70 and 60 minutes compared with 155 and 125 minutes in the control group. Median recovery time in the upper lip was 50 minutes versus 133 minutes in the control. The second publication evaluated the safety of OraVerse in children aged 4 to 11 years following a dental procedure and the efficacy and safety of OraVerse to accelerate the reversal of soft-tissue local anesthesia in children aged 6 to 11 years. No serious
'/>"/>

SOURCE Novalar Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
2. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
3. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
4. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
5. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
8. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
9. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
10. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
11. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 Southern Research ... , Ph.D., President and CEO of Southern Research ... Release Society (CRS) for the 2014-2015 term.  The ... on July 12 in Chicago ... The Controlled Release Society is ...
(Date:7/28/2014)...  MedSpring Urgent Care, an Austin -based health ... Blvd., Austin, TX 78704 on Saturday, July ... southeast corner of Barton Springs Rd. and S. Lamar ... p.m. daily, including weekends and holidays. With existing locations ... , Anderson Mill , Cedar Park ...
(Date:7/28/2014)... 28, 2014  ALPHAEON Corporation ® ... and subsidiary of Strathspey Crown Holdings ... Nutriceuticals (PRN) ® , a leading developer ... for dry eye and macular degeneration, ... worth up to $55M. ...
Breaking Medicine Technology:Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3
(Date:7/28/2014)... (HealthDay News) --,The more chronic medical conditions people have ... be, a new study claims. Since nearly ... scientists at Johns Hopkins Bloomberg School of Public Health ... gains in life expectancy are slowing in the United ... diabetes, kidney disease and heart failure is now the ...
(Date:7/28/2014)... News) -- Endurance runners are far more likely to ... according to a new study. The researchers ... warm climates are actually 10 times more likely to ... common sudden death of a young and apparently healthy ... irregular heartbeat, often gets a lot more media attention. ...
(Date:7/28/2014)... do not divide unless there is enough oxygen present ... other cell types circumvent this rule. Researchers at The ... overrides the cells, warning signals, enabling cancers to continue ... the process, the researchers found that lysosomes the ... decisions. They also uncovered new evidence that certain drugs ...
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 Parker Waichman ... years fighting to ensure that the heroes of 9/11 are ... (VCF) has announced an important deadline. According to a ... diagnosed with a covered cancer on or before October 12, ... 12, 2014. First responders and others who were allegedly injured ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The ... that has donated more than 200,000 books to children ... announces the launch of Brooke’s Cooks, a new initiative ... encouraging healthy living among at-risk children and their families ... include a series of nutrition information workshops, cooking demonstrations ...
Breaking Medicine News(10 mins):Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Cell's recycling center implicated in division decisions 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4
... contains significantly more females and includes a large proportion ... or specialized care, according to research published by researchers ... over-40 cohort, published online May 20 in the ... help guide future treatment of cystic fibrosis as survival ...
... finds , WEDNESDAY, May 19 (HealthDay News) -- For ... procedure called endovascular repair appears as good as conventional ... repair has been shown to have fewer complications and ... much shorter than with open surgery. However, questions remained ...
... next 40 years , WEDNESDAY, May 19 (HealthDay News) -- ... will more than double in the next 40 years, and the ... exceed $20 trillion, a new report from the Alzheimer,s Association finds. ... memory loss, -- it is a national crisis that grows worse ...
... men get liver cancer more often than women and opens the ... between the androgen receptor, which is more active in men, and ... The study is published May 19, 2010, in Science ... the Advancement of Science, AAAS. Primary liver cancer is the ...
... immune system in action, researchers say , WEDNESDAY, May 19 ... two different types of noninvasive probes to uncover the ... system. , One of the probes, known as an ... cells break down glucose (sugar), while the so-called FAC probe ...
... ... athlete in mind -- is proud to announce the launch of their latest collection ... time walk / run marathoners to seasoned triathletes and everyone in between. , ... (PRWEB) May 19, 2010 ...
Cached Medicine News:Health News:Older patients offer insight into the future of cystic fibrosis 2Health News:Older patients offer insight into the future of cystic fibrosis 3Health News:Less Invasive Fix for Abdominal Aortic Aneurysm Works 2Health News:Less Invasive Fix for Abdominal Aortic Aneurysm Works 3Health News:Alzheimer's Costs Could Explode by Mid-Century 2Health News:Androgen receptor may explain male dominance in liver cancer 2Health News:Androgen receptor may explain male dominance in liver cancer 3Health News:Androgen receptor may explain male dominance in liver cancer 4Health News:New Clues to Treating Immune System Disorders 2Health News:Inspired Endurance, E-tailer of Jewelry for Walkers, Runners, Marathoners and Triathletes, Introduces Endurance and Inspiration Beads Collection 2Health News:Inspired Endurance, E-tailer of Jewelry for Walkers, Runners, Marathoners and Triathletes, Introduces Endurance and Inspiration Beads Collection 3
The REVEALRT and REVEALXVI PET/CT scanners combine our fastest PET scanner, the REVEALXL, with multi-slice spiral CT scanners from Siemens Medical Systems....
... a second generation device, having evolved from ... over 700 patients beginning in 1989. Designed ... cardiologists who perform these procedures, CardioSEAL has ... the engineering bench, and in animals. In ...
Allows surgeons to successfully complete coronary artery bypass without cross clamping or side biting. Saphaneous vein grafts may be attached to the aorta without sutures....
... treat a diverse range of patients suffering ... retinal disease. Compact, Space Saving Design - ... health care professionals to use the system ... Water-cooled: The power consumption is saved by ...
Medicine Products: